Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Progesterone Receptors in Prostate Cancer: Progesterone receptor B is the isoform associated with disease progression
Thea Grindstad, Elin Richardsen, Sigve Andersen, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Progesterone: An enigmatic ligand for the mineralocorticoid receptor
Michael E. Baker, Yoshinao Katsu
Biochemical Pharmacology (2020) Vol. 177, pp. 113976-113976
Open Access | Times Cited: 51
Systemic distribution of progesterone receptor subtypes in human tissues
Teeranut Asavasupreechar, Ryoko Saito, Yasuhiro Miki, et al.
The Journal of Steroid Biochemistry and Molecular Biology (2020) Vol. 199, pp. 105599-105599
Open Access | Times Cited: 45
The 11β-hydroxysteroid dehydrogenase isoforms: pivotal catalytic activities yield potent C11-oxy C19 steroids with 11βHSD2 favouring 11-ketotestosterone, 11-ketoandrostenedione and 11-ketoprogesterone biosynthesis
Rachelle Gent, Therina du Toit, Liezl M. Bloem, et al.
The Journal of Steroid Biochemistry and Molecular Biology (2019) Vol. 189, pp. 116-126
Closed Access | Times Cited: 39
The Role of Nuclear Receptors in Prostate Cancer
Masaki Shiota, Naohiro Fujimoto, Eiji Kashiwagi, et al.
Cells (2019) Vol. 8, Iss. 6, pp. 602-602
Open Access | Times Cited: 38
Bisphenol A exposure alters hormonal modulation and responsivity in the prostate of aged female gerbils
Luara Jesus Ferrato, Thalles Fernando Rocha Ruiz, Lorena Gabriela de Souza, et al.
Molecular and Cellular Endocrinology (2025) Vol. 600, pp. 112507-112507
Closed Access
Genome-wide crosstalk between steroid receptors in breast and prostate cancers
Ville Paakinaho, Jorma J. Palvimo
Endocrine Related Cancer (2021) Vol. 28, Iss. 9, pp. R231-R250
Open Access | Times Cited: 26
Comprehensive Sex Steroid Profiling in Multiple Tissues Reveals Novel Insights in Sex Steroid Distribution in Male Mice
Hannah Colldén, Maria Nilsson, Anna‐Karin Norlén, et al.
Endocrinology (2022) Vol. 163, Iss. 3
Open Access | Times Cited: 18
Sex-specific outcomes in cancer therapy: the central role of hormones
Parisa Bakhshi, Jim Q. Ho, Saeid Zanganeh
Frontiers in Medical Technology (2024) Vol. 6
Open Access | Times Cited: 3
The 11β-hydroxyandrostenedione pathway and C11-oxy C21 backdoor pathway are active in benign prostatic hyperplasia yielding 11keto-testosterone and 11keto-progesterone
Therina du Toit, Amanda C. Swart
The Journal of Steroid Biochemistry and Molecular Biology (2019) Vol. 196, pp. 105497-105497
Closed Access | Times Cited: 22
Rapid and structure-specific cellular uptake of selected steroids
Jeffrey M. McManus, Kelsey Bohn, Mohammad Alyamani, et al.
PLoS ONE (2019) Vol. 14, Iss. 10, pp. e0224081-e0224081
Open Access | Times Cited: 22
Targeting steroid hormone receptors for anti‐cancer therapy—A review on small molecules and nanotherapeutic approaches
Namita S. Mahadik, Dwaipayan Bhattacharya, Akshaya Padmanabhan, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2021) Vol. 14, Iss. 2
Closed Access | Times Cited: 17
Changes in melatonin and sex steroid hormone production among men as a result of rotating night shift work – the HORMONIT study
Barbara N. Harding, Gemma Castaño‐Vinyals, Anna Palomar‐Cros, et al.
Scandinavian Journal of Work Environment & Health (2021) Vol. 48, Iss. 1, pp. 41-51
Open Access | Times Cited: 16
Exploiting Ligand-binding Domain Dimerization for Development of Novel Androgen Receptor Inhibitors
Christine Helsen, Tien T. Nguyen, Xiao Yin Lee, et al.
Molecular Cancer Therapeutics (2022) Vol. 21, Iss. 12, pp. 1823-1834
Open Access | Times Cited: 11
PAQR6 Upregulation Is Associated with AR Signaling and Unfavorite Prognosis in Prostate Cancers
Min Yang, Jean Chong Li, Chang Tao, et al.
Biomolecules (2021) Vol. 11, Iss. 9, pp. 1383-1383
Open Access | Times Cited: 13
The androgen receptor-targeted proteolysis targeting chimera and other alternative therapeutic choices in overcoming the resistance to androgen deprivation treatment in prostate cancer
Liuxun Li, Jiangli Xu
Clinical & Translational Oncology (2022) Vol. 25, Iss. 2, pp. 352-363
Open Access | Times Cited: 9
Molecular features of prostate cancer after neoadjuvant therapy in the phase 3 CALGB 90203 trial
Takayuki Sumiyoshi, Xiaofei Wang, Evan W. Warner, et al.
JNCI Journal of the National Cancer Institute (2023) Vol. 116, Iss. 1, pp. 115-126
Closed Access | Times Cited: 5
The potential of tumour microenvironment markers to stratify the risk of recurrence in prostate cancer patients
Thomas Gevaert, Yves‐Rémi Van Eycke, Thomas Van den Broeck, et al.
PLoS ONE (2020) Vol. 15, Iss. 12, pp. e0244663-e0244663
Open Access | Times Cited: 14
Mechanistic insights into steroid hormone-mediated regulation of the androgen receptor gene
Andrew Gillen, Irene Hunter, Ekkehard Ullner, et al.
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0304183-e0304183
Open Access | Times Cited: 1
Identification of Predictors of Shift Work Adaptation and Its Association With Immune, Hormonal and Metabolite Biomarkers
Barbara N. Harding, Ana Espinosa, Gemma Castaño‐Vinyals, et al.
Journal of Pineal Research (2024) Vol. 76, Iss. 8
Open Access | Times Cited: 1
Genome-wide association study identifies a role for the progesterone receptor in benign prostatic hyperplasia risk
Weiqiang Li, Robert J. Klein
Prostate Cancer and Prostatic Diseases (2020) Vol. 24, Iss. 2, pp. 492-498
Closed Access | Times Cited: 10
Co-Adjuvant Therapy Efficacy of Catechin and Procyanidin B2 with Docetaxel on Hormone-Related Cancers In Vitro
Ma Jesús Núñez-Iglesias, Silvia Novío, Carlota Garcı́a, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 7178-7178
Open Access | Times Cited: 8
Progesterone and its metabolite allopregnanolone promote invasion of human glioblastoma cells through metalloproteinase‑9 and cSrc kinase
Claudia Bello‐Alvarez, Carmen J. Zamora-Sánchez, Karla Mariana Peña‐Gutiérrez, et al.
Oncology Letters (2023) Vol. 25, Iss. 6
Open Access | Times Cited: 3
Trends in estrogen and progesterone receptors in prostate cancer: a bibliometric analysis
Wenqiang Liao, Xuxia Sui, Gaoming Hou, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
Progesterone Receptor Expression in the Benign Prostatic Hyperplasia and Prostate Cancer Tissues, Relation with Transcription, Growth Factors, Hormone Reception and Components of the AKT/mTOR Signaling Pathway
Л. В. Спирина, И. В. Ковалева, Evgeny A. Usynin, et al.
Asian Pacific Journal of Cancer Prevention (2020) Vol. 21, Iss. 2, pp. 423-429
Open Access | Times Cited: 8
Chromatin accessibility analysis uncovers regulatory element landscape in prostate cancer progression
Joonas Uusi-Mäkelä, Ebrahim Afyounian, Francesco Tabaro, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top